Search

everythinglearnresearchcommunity

for

Search:↓

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Early adrenal gland maturation in young children can be normal, but other serious conditions should be ruled out first.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

Flutamide improves female hair loss when other treatments fail, but may cause liver toxicity.

Recent genetic insights show that low-renin hypertension includes a range from essential hypertension to secondary or familial forms, affecting diagnosis and treatment.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Vegetarian Indian women with PCOS have higher inflammation levels than non-vegetarians.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Hormonal treatments can improve acne, but they come with potential side effects and risks.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

New male hormonal contraceptives show promise but need more research on long-term effects and funding for larger trials.

Taking oral testosterone with finasteride or dutasteride doubles testosterone levels, and food slightly affects it.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Low vitamin D receptor levels found in hair loss patients; topical vitamin D treatment suggested.

Women with mild acne are more likely to have polycystic ovary syndrome (PCOS) than those without acne.

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

Testosterone replacement therapy should be used for men with low testosterone levels and symptoms of hypogonadism, after careful diagnosis and considering individual needs.

Spironolactone can reduce hair growth and testosterone in hirsutism, but is less effective than combined treatments.

Obesity changes androgen levels in women with PCOS, leading to higher testosterone relative to androstenedione.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.

Hair can indicate early signs of metabolic disorders, with issues like protein deficiency stopping hair growth.

Menopausal acne is treated with medications and lifestyle changes, but careful choice is needed due to side effects.

Blood tests are needed to confirm high male hormone levels in women with PCOS, as physical signs alone are not reliable.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Finasteride does not prevent bladder cancer.

Androgens may influence bladder cancer progression by affecting cellular behavior.

Alternative treatments show promise for hair growth beyond traditional methods.

Researchers created a lab model to study human hair growth, showing it can grow and self-regulate outside the body.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.